Kerra Pearce

1.7k total citations
15 papers, 444 citations indexed

About

Kerra Pearce is a scholar working on Molecular Biology, Hematology and Epidemiology. According to data from OpenAlex, Kerra Pearce has authored 15 papers receiving a total of 444 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Hematology and 3 papers in Epidemiology. Recurrent topics in Kerra Pearce's work include Protein Degradation and Inhibitors (3 papers), Acute Myeloid Leukemia Research (2 papers) and Congenital Heart Disease Studies (2 papers). Kerra Pearce is often cited by papers focused on Protein Degradation and Inhibitors (3 papers), Acute Myeloid Leukemia Research (2 papers) and Congenital Heart Disease Studies (2 papers). Kerra Pearce collaborates with scholars based in United Kingdom, United States and Netherlands. Kerra Pearce's co-authors include Peter Scambler, Andrew Feber, Stephan Beck, Andrew E. Teschendorff, Matthias Lechner, Christina Thirlwell, Martin Widschwendter, Owen Williams, Tony Brooks and Stuart Adams and has published in prestigious journals such as The Lancet, PLoS ONE and Cancer Research.

In The Last Decade

Kerra Pearce

15 papers receiving 437 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kerra Pearce United Kingdom	12	276	105	52	51	48	15	444
Pietro Sirleto Italy	12	221 0.8×	137 1.3×	40 0.8×	31 0.6×	31 0.6×	25	399
Dmitry Penkov Russia	13	407 1.5×	79 0.8×	22 0.4×	26 0.5×	56 1.2×	27	556
Kristbjorn O. Gudmundsson United States	13	195 0.7×	69 0.7×	66 1.3×	111 2.2×	42 0.9×	23	400
Fatemehsadat Esteghamat Iran	13	191 0.7×	72 0.7×	124 2.4×	87 1.7×	20 0.4×	17	412
Michelle Nguyen-McCarty United States	7	283 1.0×	38 0.4×	59 1.1×	87 1.7×	67 1.4×	8	398
Pamela Brock United States	15	277 1.0×	286 2.7×	55 1.1×	40 0.8×	103 2.1×	39	712
Inger M. Olsen Denmark	8	227 0.8×	72 0.7×	18 0.3×	33 0.6×	47 1.0×	10	488
Chiara Fallerini Italy	14	237 0.9×	132 1.3×	52 1.0×	103 2.0×	38 0.8×	31	556
Erik L. Bao United States	10	314 1.1×	74 0.7×	53 1.0×	61 1.2×	68 1.4×	14	538
Adi Mory Israel	15	245 0.9×	147 1.4×	31 0.6×	46 0.9×	18 0.4×	40	592

Countries citing papers authored by Kerra Pearce

Since Specialization

Citations

This map shows the geographic impact of Kerra Pearce's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kerra Pearce with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kerra Pearce more than expected).

Fields of papers citing papers by Kerra Pearce

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kerra Pearce. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kerra Pearce. The network helps show where Kerra Pearce may publish in the future.

Co-authorship network of co-authors of Kerra Pearce

This figure shows the co-authorship network connecting the top 25 collaborators of Kerra Pearce. A scholar is included among the top collaborators of Kerra Pearce based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kerra Pearce. Kerra Pearce is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Warren, Daniel, Shivaram Avula, D. S. Bhattacharya, et al.. (2023). Review of standard paediatric neuroradiology MRI protocols from 12 UK tertiary paediatric hospitals: is there much variation between centres?. Clinical Radiology. 78(12). e941–e949. 1 indexed citations

Armenteros-Monterroso, Elena, Lu Zhao, Luca Gasparoli, et al.. (2019). The AAA+ATPase RUVBL2 is essential for the oncogenic function of c-MYB in acute myeloid leukemia. Leukemia. 33(12). 2817–2829. 17 indexed citations

Vadgama, Nirmal, Alan Pittman, Michael A. Simpson, et al.. (2019). De novo single-nucleotide and copy number variation in discordant monozygotic twins reveals disease-related genes. European Journal of Human Genetics. 27(7). 1121–1133. 19 indexed citations

Pearce, Kerra, Tony Brooks, Michael Hubank, et al.. (2017). Targeting acute myeloid leukemia by drug-induced c-MYB degradation. Leukemia. 32(4). 882–889. 78 indexed citations

Bacchelli, Chiara, Federico A. Moretti, Marlene Carmo, et al.. (2016). Mutations in linker for activation of T cells (LAT) lead to a novel form of severe combined immunodeficiency. Journal of Allergy and Clinical Immunology. 139(2). 634–642.e5. 31 indexed citations

Henriquez, Nico V., Tim Forshew, Ruth Tatevossian, et al.. (2013). Comparative Expression Analysis Reveals Lineage Relationships between Human and Murine Gliomas and a Dominance of Glial Signatures during Tumor Propagation In Vitro. Cancer Research. 73(18). 5834–5844. 24 indexed citations

Rahman, Shamima, Russell Ecob, Harry Costello, et al.. (2012). Hearing in 44–45 year olds with m.1555A>G, a genetic mutation predisposing to aminoglycoside-induced deafness: a population based cohort study. BMJ Open. 2(1). e000411–e000411. 38 indexed citations

Meschia, James F., Andrew Singleton, Michael A. Nalls, et al.. (2011). Genomic Risk Profiling of Ischemic Stroke: Results of an International Genome-Wide Association Meta-Analysis. PLoS ONE. 6(9). e23161–e23161. 12 indexed citations

Meschia, James F., Michael A. Nalls, Mar Matarín, et al.. (2011). Siblings With Ischemic Stroke Study. Stroke. 42(10). 2726–2732. 20 indexed citations

10.

Thirlwell, Christina, Andrew Feber, Andrew E. Teschendorff, et al.. (2010). Genome-wide DNA methylation analysis of archival formalin-fixed paraffin-embedded tissue using the Illumina Infinium HumanMethylation27 BeadChip. Methods. 52(3). 248–254. 78 indexed citations

11.

Bueren, Kelly Lammerts van, Irinna Papangeli, Francesca Rochais, et al.. (2010). Hes1 expression is reduced in Tbx1 null cells and is required for the development of structures affected in 22q11 deletion syndrome. Developmental Biology. 340(2). 369–380. 49 indexed citations

12.

Haelst, Mieke M. van, Geneviève Baujat, Shalini Jadeja, et al.. (2008). Molecular study of 33 families with Fraser syndrome new data and mutation review. American Journal of Medical Genetics Part A. 146A(17). 2252–2257. 54 indexed citations

13.

Bueren, Kelly Lammerts van, Sarah Ivins, Catherine Roberts, et al.. (2007). Identification of potential Tbx1 targets in a mouse model of DiGeorge syndrome. Developmental Biology. 306(1). 323–323. 1 indexed citations

14.

Pearce, Kerra & P. O. Yates. (1965). Blood groups and brain tumours. Journal of the Neurological Sciences. 2(5). 434–441. 7 indexed citations

15.

Pearce, Kerra, et al.. (1960). RECENT CHANGE IN BLOOD-GROUP. The Lancet. 275(7117). 194–195. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact